Drug
BH4
BH4 is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_1
3
75%
Ph phase_4
1
25%
Phase Distribution
3
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 13 (75.0%)
Phase 41 (25.0%)
Trials by Status
completed250%
recruiting125%
unknown125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_1
Novel Approaches for Improving Vascular Function in Veterans With HFpEF
NCT06312748
completedphase_1
Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment
NCT02530996
unknownphase_4
BH4 Responsiveness in PAH Deficiency PKU Patients
NCT04227080
completedphase_1
The Effect of Antioxidants on Skin Blood Flow-BH4
NCT03680573
Clinical Trials (4)
Showing 4 of 4 trials
NCT06312748Phase 1
Novel Approaches for Improving Vascular Function in Veterans With HFpEF
NCT02530996Phase 1
Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment
NCT04227080Phase 4
BH4 Responsiveness in PAH Deficiency PKU Patients
NCT03680573Phase 1
The Effect of Antioxidants on Skin Blood Flow-BH4
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4